Shares of NeoStem (NBS +11%) post double-digit gains on above-average volume. Earlier today the company appointed Stephen Potter Executive VP. Potter most recently served as Senior VP of Operations at Osiris Therapeutics and previously was Senior VP of Corporate and Business Development at Genzyme. (Also: SA contributor Equity Options Guru says "key milestones" should get investors excited about NBS)
Shares of NeoStem (NBS +11%) post double-digit gains on above-average volume. Earlier today the...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs